首页 | 本学科首页   官方微博 | 高级检索  
     


SARS-CoV-2 IgG Seroprevalence among Blood Donors as a Monitor of the COVID-19 Epidemic,Brazil
Authors:Daniel Gonç  alves Chaves,Ricardo Hiroshi Caldeira Takahashi,Felipe Campelo,Maria Clara Fernandes da Silva Malta,Isabelle Rocha de Oliveira,Edel Figueiredo Barbosa-Stancioli,Maí  sa Aparecida Ribeiro,Marina Lobato Martins
Affiliation:Fundação Hemominas, Belo Horizonte, Brazil (D.G. Chaves, M.C.F. da Silva Malta, M.A. Ribeiro, M.L. Martins);Universidade Federal de Minas Gerais, Belo Horizonte (R.H.C. Takahashi, F. Campelo, I.R. de Oliveira, E.F. Barbosa-Stancioli);Aston University, Birmingham, UK (F. Campelo)
Abstract:During epidemics, data from different sources can provide information on varying aspects of the epidemic process. Serology-based epidemiologic surveys could be used to compose a consistent epidemic scenario. We assessed the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgG in serum samples collected from 7,837 blood donors in 7 cities of Brazil during March–December 2020. Based on our results, we propose a modification in a compartmental model that uses reported number of SARS-CoV-2 cases and serology results from blood donors as inputs and delivers estimates of hidden variables, such as daily values of SARS-CoV-2 transmission rates and cumulative incidence rate of reported and unreported SARS-CoV-2 cases. We concluded that the information about cumulative incidence of a disease in a city’s population can be obtained by testing serum samples collected from blood donors. Our proposed method also can be extended to surveillance of other infectious diseases.
Keywords:COVID-19   respiratory infections   severe acute respiratory syndrome coronavirus 2   SARS-CoV-2   SARS   coronavirus disease   zoonoses   viruses   coronavirus   blood donor   epidemic model   seroprevalence   Brazil
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号